The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment
Abstract
Dermatofibrosarcoma protuberans (DP) is a rare, slow‐growing, infiltrating dermal neoplasm of intermediate malignancy, made up of spindle‐shaped tumor cells often positive for CD34. The preferred treatment is wide surgical excision with pathologically negative margins. At the cytogenetic level, DP cells are characterized by either supernumerary ring chromosomes, which have been shown by using fluorescence in situ hybridization techniques to be derived from chromosome 22 and to contain low‐level amplified sequences from 17q22‐qter and 22q10–q13.1, or t(17;22), that are most often unbalanced. Both the rings and linear der(22) contain a specific fusion of COL1A1 with PDGFB. Similar to other tumors, the COL1A1‐PDGFB fusion is occasionally cryptic, associated with complex chromosomal rearrangements. Although rings have been mainly observed in adults, translocations have been reported in all pediatric cases. DP is therefore a unique example of a tumor in which (i) the same molecular event occurs either on rings or linear translocation derivatives, (ii) the chromosomal abnormalities display an age‐related pattern, and (iii) the presence of the specific fusion gene is associated with the gain of chromosomal segments, probably taking advantage of gene dosage effects. In all DP cases that underwent molecular investigations, the breakpoint localization in PDGFB was found to be remarkably constant, placing exon 2 under the control of the COL1A1 promoter. In contrast, the COL1A1 breakpoint was found to be variably located within the exons of the α‐helical coding region (exons 6–49). No preferential COL1A1 breakpoint and no correlation between the breakpoint location and the age of the patient or any clinical or histological particularity have been described. The COL1A1‐PDGFB fusion is detectable by multiplex RT‐PCR with a combination of forward primers designed from a variety of COL1A1 exons and one reverse primer from PDGFB exon 2. Recent studies have determined the molecular identity of “classical” DP, giant cell fibroblastoma, Bednar tumor, adult superficial fibrosarcoma, and the granular cell variant of DP. In approximately 8% of DP cases, the COL1A1‐PDGFB fusion is not found, suggesting that genes other than COL1A1 or PDGFB might be involved in a subset of cases. It has been proposed that PDGFB acts as a mitogen in DP cells by autocrine stimulation of the PDGF receptor. It is encouraging that inhibitory effects of the PDGF receptor tyrosine kinase antagonist imatinib mesylate have been demonstrated in vivo; such targeted therapies might be warranted in the near future for treatment of the few DP cases not manageable by surgery. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., et al. (2002) · Nature · doi:10.1038/nature00870 · Cited by 5,518
RetractedEffects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Waterfield, M. D., Scrace, G. T., Whittle, N., Stroobant, P., Johnsson, A., Wasteson, Å., Westermark, B., Heldin, C.-H., Huang, J. S., & Deuel, T. F. (1983) · Nature · doi:10.1038/304035a0 · Cited by 1,616
Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects
(2002) · Wiley eBooks · doi:10.1002/0471221929 · Cited by 949
Kransdorf, M. J. (1995) · American Journal of Roentgenology · doi:10.2214/ajr.164.1.7998525 · Cited by 743
Druker, B. J., & Lydon, N. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9083 · Cited by 707
Carroll, M., Ohno-Jones, S., Tamura, S., Buchdunger, E., Zimmermann, J., Lydon, N. B., Gilliland, D. G., & Druker, B. J. (1997) · Blood · doi:10.1182/blood.v90.12.4947 · Cited by 554
Simon, M.-P., Pedeutour, F., Sirvent, N., Grosgeorge, J., Minoletti, F., Coindre, J.-M., Terrier-Lacombe, M.-J., Mandahl, N., Craver, R., Blin, N., et al. (1997) · Nature Genetics · doi:10.1038/ng0197-95 · Cited by 535
Self-citationIn Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor
le Coutre, P., Mologni, L., Cleris, L., Marchesi, E., Buchdunger, E., Giardini, R., Formelli, F., & Gambacorti-Passerini, C. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.163 · Cited by 374
Rubin, B. P., Schuetze, S. M., Eary, J. F., Norwood, T. H., Mirza, S. K., Conrad, E. U., & Bruckner, J. D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.027 · Cited by 364
Dermatofibrosarcoma protuberans
Gloster, H. M. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90597-6 · Cited by 352
The human type I collagen mutation database
Dalgleish, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.1.181 · Cited by 313
Shimizu, A., O'Brien, K. P., Sjöblom, T., et al. (1999) · PubMed · Cited by 289
Maki, R. G., Awan, R. A., Dixon, R. H., Jhanwar, S., & Antonescu, C. R. (2002) · International Journal of Cancer · doi:10.1002/ijc.10535 · Cited by 250
New Members of the Platelet-Derived Growth Factor Family of Mitogens
Heldin, C.-H., Eriksson, U., & Östman, A. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2707 · Cited by 221
Dupree, W. B., Langloss, J. M., & Weiss, S. W. (1985) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198509000-00002 · Cited by 182
The Role of Radiation Therapy in the Management of Dermatofibrosarcoma Protuberans
Ballo M.D., M. T., Zagars M.D., G. K., Pisters M.D., P., & Pollack M.D., P. D. (1998) · International Journal of Radiation OncologyBiologyPhysics · doi:10.1016/s0360-3016(97)00895-x · Cited by 180
Kutzner, H. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(93)70083-6 · Cited by 175
In Vivo Amplification of the PAX3-FKHR and PAX7-FKHR Fusion Genes in Alveolar Rhabdomyosarcoma
Barr, F. G., Nauta, L. E., Davis, R. J., Schäfer, B. W., Nycum, L. M., & Biegel, J. A. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.1.15 · Cited by 151
Pédeutour, F., Simon, M., Minoletti, F., Sozzi, G., Pierotti, M. A., Hecht, F., & Turc‐Carel, C. (1995) · PubMed · Cited by 130
Greco, A., Fusetti, L., Villa, R., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202051 · Cited by 116
Simon, M., Navarro, M., Roux, D., & Pouysségur, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204426 · Cited by 109
Tomasson, M. H., Williams, I. R., Hasserjian, R. P., Udomsakdi, C., McGrath, S. M., Schwaller, J., Druker, B. J., & Gilliland, D. G. (1999) · Blood · doi:10.1182/blood.v93.5.1707 · Cited by 108
Martin, Meunier, Montels, & Watts (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.1390s2008.x · Cited by 108
Dermatofibrosarcoma Protuberans Harboring t(9;22)(q32;q12.2)
Sonobe, H., Furihata, M., Iwata, J., Ohtsuki, Y., Chikazawa, M., Taguchi, T., & Shimizu, K. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00183-6 · Cited by 44
Cited by
Role of platelet-derived growth factors in physiology and medicine
Andrae, J., Gallini, R., & Betsholtz, C. (2008) · Genes & Development · doi:10.1101/gad.1653708 · Cited by 2,438
The impact of translocations and gene fusions on cancer causation
Mitelman, F., Johansson, B., & Mertens, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2091 · Cited by 1,400
PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma
Östman, A. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.002 · Cited by 326
Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
Schram, A. M., Chang, M. T., Jonsson, P., & Drilon, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.127 · Cited by 323
Transcriptional characterizations of differences between eutopic and ectopic endometrium
Wu, Y., Kajdacsy-Balla, A., Strawn, E., Basir, Z., Halverson, G., Jailwala, P., Wang, Y., Wang, X., Ghosh, S., & Guo, S.-W. (2006) · Endocrinology · doi:10.1210/en.2005-0426 · Cited by 208
Metadata
- Authors
- Sirvent, N., Maire, G., & Pedeutour, F.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 2003-03-11
- Volume
- 37
- Issue
- 1
- Pages
- 1-19
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W2155513152
- Cited by
- 310
- References
- 25
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.